MRI-derived real PSA density for risk stratification of PI-RADS 3 lesions: A rule-in approach for clinically significant prostate cancer
{{output}}
Management of PI-RADS 3 lesions remains challenging due to their variable probability of clinically significant prostate cancer (csPCa). Conventional prostate-specific antigen density (PSAD) assumes homogeneous PSA production across the prostate, which may not... ...
